GoHealth
GOCO
GOCO was delisted on the 15th of June, 2026.
90 hedge funds and large institutions have $1.11B invested in GoHealth in 2020 Q3 according to their latest regulatory filings, with 90 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
59% more call options, than puts
Call options by funds: $1.38M | Put options by funds: $872K
6.77% more ownership
Funds ownership: 0% → 6.77% (+6.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Centerbridge Partners
New York
|
+$653M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$93.3M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$75.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.6M |
| 5 |
BlackRock
New York
|
+$54.3M |
Top Sellers
GOCO Hedge Fund Activity: Q3 2020 in Review
90 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in GoHealth (GOCO) for Q3 2020, worth a combined $1.11B.
Buyers outnumbered sellers: 90 funds opened new GOCO positions and 0 closed out — a net gain of 90 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Centerbridge Partners, opening a new position worth an estimated $653M.
- 90 institutional investors held GoHealth (GOCO) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $1.11B of GoHealth stock for Q3 2020.
- 90 funds opened new GoHealth positions in Q3 2020 and 0 closed out, a net change of +90 holders.
- The largest GoHealth buyer in Q3 2020 was Centerbridge Partners, an estimated $653M added.
Based on aggregated 13F filings for Q3 2020.